Voozh

We are passionate about supporting the local pharma industries with high-quality products for the markets. Our track record in product development and collaborations with global entities reflects our dedication.

Our portfolio solution Finished Dosage Forms is fueled by our collaborations. We are constantly working to amplify these partnerships to the benefit of our customers. To learn more about our partnerships, click here.

At HELM, we stand as your reliable ally to “Invent Success. Every day”, as we are inspired by making our customers and partners successful and always trust in ourselves to offer the best solutions for your needs, constantly.

Know more about us

Finished Dosage Forms

With headquarters in Hamburg, we establish strong partnerships to bring an idea to market and have flexibility responding to your strategic goals, enabling you to be ahead of the game.

Know more

2021

Finished Dosage Forms:
Calcipotriol + Betamethasone gel First to Launch in EU

2020

Finished Dosage Forms:
Estradiol vaginal first to launch in EU
Ulipristal 30 mg from HELM is the only generic approved in EU

2019

Finished Dosage Forms:
Fentanyl buccal first to launch in EU

2018

Finished Dosage Forms:
Brivudine first to launch in EU

1993

Finished Dosage Forms:
1st product development, Calcitonin, used to combat osteoporosis

1973

Foundation of HELM Pharma start with trading of Active Pharmaceutical Ingredients (API)

URL: https://helmpharma.com/helm-pharma/about-us